<?xml version='1.0' encoding='utf-8'?>
<document id="26235578"><sentence text="Effect of Piperazine Dithioctate on the Oral Pharmacokinetics of Glimepiride in Rats."><entity charOffset="10-32" id="DDI-PubMed.26235578.s1.e0" text="Piperazine Dithioctate" /><entity charOffset="65-76" id="DDI-PubMed.26235578.s1.e1" text="Glimepiride" /><pair ddi="false" e1="DDI-PubMed.26235578.s1.e0" e2="DDI-PubMed.26235578.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26235578.s1.e0" e2="DDI-PubMed.26235578.s1.e1" /></sentence><sentence text="The objective of the present work was to investigate the potential for pharmacokinetic drug-drug interactions between glimepiride (GMP) and piperazine dithioctate (PDT) in rats to support the development of an orally combined product of the two drugs"><entity charOffset="118-129" id="DDI-PubMed.26235578.s2.e0" text="glimepiride" /><entity charOffset="140-162" id="DDI-PubMed.26235578.s2.e1" text="piperazine dithioctate" /><pair ddi="false" e1="DDI-PubMed.26235578.s2.e0" e2="DDI-PubMed.26235578.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26235578.s2.e0" e2="DDI-PubMed.26235578.s2.e1" /></sentence><sentence text=" An LC-MS/MS bioanalytical method was developed for simultaneous quantification of GMP and thioctic acid (TA) in rat plasma"><entity charOffset="91-104" id="DDI-PubMed.26235578.s3.e0" text="thioctic acid" /><entity charOffset="106-108" id="DDI-PubMed.26235578.s3.e1" text="TA" /><pair ddi="false" e1="DDI-PubMed.26235578.s3.e0" e2="DDI-PubMed.26235578.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26235578.s3.e0" e2="DDI-PubMed.26235578.s3.e1" /></sentence><sentence text=" The accuracy, precision, linearity, selectivity, and recovery were all within an acceptable range" /><sentence text=" The oral plasma exposure of the GMP solution was more than 14-times greater than that of the GMP suspension at a dose of 0" /><sentence text="5 mg/kg, suggesting a dissolution-limited absorption of the GMP suspension" /><sentence text=" Oral co-administration of PDT (72 mg/kg) with GMP suspension (0" /><sentence text="5 mg/kg) reduced the plasma GMP exposure by approximately 80% without a significant change in t1/2 and tmax" /><sentence text=" Oral co-administration of PDT with GMP solution had no significant effect on the plasma pharmacokinetics of GMP" /><sentence text=" PDT lowered the pH (from ca" /><sentence text=" 7 to 5" /><sentence text="6) and the dissolved GMP concentration in the GMP suspension" /><sentence text=" It was also shown that GMP was more soluble at pH 7 than at 5" /><sentence text="7 in an aqueous solution, and the oral plasma exposure of a GMP suspension at pH 7" /><sentence text="0 was substantially higher than that of a suspension at pH 5" /><sentence text="7" /><sentence text=" These results suggest that the pH-dependent solubility of GMP was likely responsible for PDT's effect on the oral absorption of GMP" /><sentence text=" In conclusion, the current work suggests a possibility of drug-drug interaction between GMP and PDT upon oral co-administration" /><sentence text=" " /></document>